• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CBIZ Report Highlights Rising Costs: Surge in Inpatient and Outpatient Expenses, Popular GLP-1 Drugs like Ozempic Drive Pharmacy Spend Increase

By: CBIZ, Inc. via Business Wire
May 20, 2025 at 09:00 AM EDT

New CBIZ State of Healthcare Report Reveals Cost Increases, Significant Impact of GLP-1 Drugs on Pharmacy Spend, and Regulatory Changes Expanding Employee Protections and Accessibility

CBIZ, Inc. (NYSE: CBZ), a leading national professional services advisor, announced the release of its 2025 State of Healthcare Report. The report provides a data-driven look at trends affecting employer-sponsored healthcare and the strategies organizations are using to stay competitive.

Now, more than ever, employers face increased pressure to balance affordability with employee wellbeing as healthcare costs continue to rise. The State of Healthcare Report draws on CBIZ’s proprietary data from more than 290,000 plan members, delivering insights into care delivery, cost containment, and regulatory compliance.

Key insights from the report:

  • Healthcare costs continue to rise, with CBIZ data finding that cost per visit for inpatient, outpatient, and professional care increased from 2022 to 2024.
  • CBIZ data shows that GLP-1s are a significant cost driver in employers’ pharmacy spend. GLP-1 spend as a percentage of overall pharmacy spend has increased from 9% in 2022 to 17% in 2024. This trend is expected to continue as these medications grow in popularity.
  • Ongoing regulatory changes, specifically those occurring at the state level, are shifting employer-sponsored healthcare. Many of these regulations expand protections and accessibility for employees, and employers must continue to monitor relevant legislation to maintain compliance.

“Healthcare has never been more complex than it is right now,” said Cole Harris, Business Unit President, National Practice Leader for Health Innovations. “The report is designed to give employers real data-driven insights and forward-looking guidance to navigate our increasingly complex environment.”

The State of Healthcare Report provides a high-level overview of emerging risks and opportunities, featuring analysis from our experts on how to proactively tackle these challenges through data, innovation, and smarter benefits design.

To download the full report, visit 2025 State of Healthcare Report

About CBIZ

CBIZ, Inc. (NYSE: CBZ) is a leading professional services advisor to middle market businesses and organizations nationwide. With unmatched industry knowledge and expertise in accounting, tax, advisory, benefits, insurance, and technology, CBIZ delivers forward-thinking insights and actionable solutions to help clients anticipate what's next and discover new ways to accelerate growth. CBIZ has more than 10,000 team members across more than 160 locations in 22 major markets coast to coast. For more information, visit www.cbiz.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250520808811/en/

Contacts

Media: Amy McGahan, Director of Corporate & Strategic Communications, amy.mcgahan@cbiz.com

More News

View More
Rocket Lab: A Parabolic Run Meets a Healthy Pullback
Today 17:07 EDT
Via MarketBeat
Tickers RKLB
Falling Fast, Rising Soon? 3 Stocks With Upside Ahead
Today 16:22 EDT
Via MarketBeat
Topics Earnings
Tickers ALLT ARDT GPI
The Top 120 Lesser-Known Affordable Luxury Vacation Spots in the U.S.
Today 16:15 EDT
Via MarketBeat
Healthcare Stocks Hit Valuation Bottom, 3 Names to Rebound
Today 16:13 EDT
Via MarketBeat
Topics Artificial Intelligence
Tickers LLY PFE UNH
Is Former Dividend Aristocrat AT&T a Buy After Q2 Earnings?
Today 13:41 EDT
Via MarketBeat
Topics Earnings
Tickers T TMUS VZ
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap